Exogenous estrogen rapidly attenuates pulmonary artery vasoreactivity and acute hypoxic pulmonary vasoconstriction

Shock

Volumn 30, Issue 6, 2008, Pages 660-667

  Lahm, Tim ^a   Crisostomo, Paul R ^a   Markel, Troy A ^a   Wang, Meijing ^a   Wang, Yue ^a   Weil, Brent ^a   Meldrum, Daniel R ^a,b  

^a INDIANA UNIVERSITY   (United States)

^b MS 2017 ^*

Author keywords

17 estradiol; Estrous cycle; Nongenomic effects; Phenylephrine; Sex differences; Sex hormones

Indexed keywords

CARBON DIOXIDE; ESTRADIOL; OXYGEN; PHENYLEPHRINE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIESTRUS; DRUG MECHANISM; ESTRUS; FEMALE; HYPOXIC LUNG VASOCONSTRICTION; ISOMETRICS; LUNG ARTERY; LUNG VASOCONSTRICTION; MALE; METESTRUS; NONHUMAN; PROESTRUS; RAT; SPRAGUE DAWLEY RAT; VASODILATATION;

ANIMALS; ANOXIA; CARBON DIOXIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGENS; FEMALE; MALE; PHENYLEPHRINE; PULMONARY ARTERY; RATS; RATS, SPRAGUE-DAWLEY; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 58149234707     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e31816f239f     Document Type: Article

References (39)

1. McLaughlin VV. McGoon MD: Pulmonary arterial hypertension. Circulation 114:1417-1431. 2006.
2. Rabinovitch M. Gamble WJ. Miettinen OS. Reid L: Age and sex influence on pulmonary hypertension of chronic hypoxia and on recovery. Am J Physiol 240:H62-H72, 1981.
3. Resta TC. Kanagy NL. Walker BR: Estradiol-induced attenuation of pulmonary hypertension is not associated with altered eNOS expression. Am J Physiol Lung Cell Mol Physiol 280:L88-L97. 2001.
4. Tofovic SP, Zhang X. Jackson EK. Dacic S. Petrusevska G: 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension. Vascul Pharmacol 45:358-367. 2006.
5. Lahm T, Patel KM, Crisostomo PR, Markel TA, Wang M, Herring C, Meldrum DR: Endogenous estrogen attenuates pulmonary artery vasoreactivity and acute hypoxic pulmonary vasoconstriction: the effects of sex and menstrual cycle. Am J Physiol Endocrinol Metab 293:E865-E871, 2007.
6. Earley S, Resta TC: Estradiol attenuates hypoxia-induced pulmonary endothelin- 1 gene expression. Am J Physiol Lung Cell Mol Physiol 283:L86-L93, 2002.
7. English KM, Jones RD, Jones TH, Morice AH, Channer KS: Gender differences in the vasomotor effects of different steroid hormones in rat pulmonary and coronary arteries. Horm Metab Res 33:645-652, 2001.
8. Crisostomo PR, Wang M, Herring CM, Morrell ED, Seshadri P, Meldrum KK, Meldrum DR: Sex dimorphisms in activated mesenchymal stem cell function. Shock 26:571-574, 2006.
9. Choudhry MA, Schwacha MG, Hubbard WJ, Kerby JD, Rue LW, Bland KI, Chaudry IH: Gender differences in acute response to trauma-hemorrhage. Shock 24(Suppl 1):101-106, 2005.
10. Meldrum DR: G-protein-coupled receptor 30 mediates estrogen's nongenomic effects after hemorrhagic shock and trauma. Am J Pathol 170:1148-1151, 2007.
11. Morrell ED, Tsai BM, Crisostomo PR, Hammoud ZT, Meldrum DR: Experimental therapies for hypoxia-induced pulmonary hypertension during acute lung injury. Shock 25:214-226, 2006.
12. Wetzel RC, Zacur HA, Sylvester JT: Effect of puberty and estradiol on hypoxic vasomotor response in isolated sheep lungs. J Appl Physiol 56: 1199-1203, 1984.
13. Gordon JB, Wetzel RC, McGeady ML, Adkinson NF Jr, Sylvester JT: Effects of indomethacin on estradiol-induced attenuation of hypoxic vasoconstriction in lamb lungs. J Appl Physiol 61:2116-2121, 1986.
14. Yokoyama Y, Kuebler JF, Matsutani T, Schwacha MG, Bland KI, Chaudry IH: Mechanism of the salutary effects of 17beta-estradiol following traumahemorrhage: direct downregulation of Kupffer cell proinflammatory cytokine production. Cytokine 21:91-97, 2003.
15. Suzuki T, Shimizu T, Yu HP, Hsieh YC, Choudhry MA, Chaudry IH: Salutary effects of 17beta-estradiol on T-cell signaling and cytokine production after trauma-hemorrhage are mediated primarily via estrogen receptor- {alpha}. Am J Physiol Cell Physiol 292:C2103-C2111, 2007.
16. Suzuki T, Yu HP, Hsieh YC, Choudhry MA, Bland KI, Chaudry IH: Estrogenmediated activation of non-genomic pathway improves macrophages cytokine production following trauma-hemorrhage. J Cell Physiol 214:662-672, 2007.
17. Hubscher CH, Brooks DL, Johnson JR: A quantitative method for assessing stages of the rat estrous cycle. Biotech Histochem 80:79-87, 2005.
18. Warner M, Gustafsson JA: Nongenomic effects of estrogen: why all the uncertainty? Steroids 71:91-95, 2006.
19. Gonzales RJ, Walker BR, Kanagy NL: 17Beta-estradiol increases nitric oxidedependent dilation in rat pulmonary arteries and thoracic aorta. Am J Physiol Lung Cell Mol Physiol 280:L555-L564, 2001.
20. Lahm T, Crisostomo PR, Markel TA, Wang M, Lillemoe KD, Meldrum DR: The critical role of vascular endothelial growth factor in pulmonary vascular remodeling after lung injury. Shock 28:4-14, 2007.
21. Liu SF, Dewar A, Crawley DE, Barnes PJ, Evans TW: Effect of tumor necrosis factor on hypoxic pulmonary vasoconstriction. J Appl Physiol 72:1044-1049, 1992.
22. Stenmark KR, Fagan KA, Frid MG: Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res 99:675-691, 2006.
23. Wang M, Crisostomo P, Wairiuko GM, Meldrum DR: Estrogen receptor-alpha mediates acute myocardial protection in females. Am J Physiol Heart Circ Physiol 290:H2204-H2209, 2006.
24. Lantin-Hermoso RL, Rosenfeld CR, Yuhanna IS, German Z, Chen Z, Shaul PW: Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. Am J Physiol 273:L119-L126, 1997.
25. Sherman TS, Chambliss KL, Gibson LL, Pace MC, Mendelsohn ME, Pfister SL, Shaul PW: Estrogen acutely activates prostacyclin synthesis in ovine fetal pulmonary artery endothelium. Am J Respir Cell Mol Biol 26:610-616, 2002.
26. Murphy E, Steenbergen C: Cardioprotection in females: a role for nitric oxide and altered gene expression. Heart Fail Rev 12:293-300, 2007.
27. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, et al.: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288:321-333, 2002.
28. Barlow DH: Oestrogen implant overdose. Lancet 2:392-393, 1988.
29. Yu HP, Hsieh YC, Suzuki T, Shimizu T, Choudhry MA, Schwacha MG, Chaudry IH: Salutary effects of estrogen receptor-beta agonist on lung injury after trauma-hemorrhage. Am J Physiol Lung Cell Mol Physiol 290: L1004-L1009, 2006.
30. Lomas-Neira J, Chung CS, Perl M, Gregory S, Biffl W, Ayala A: Role of alveolar macrophage and migrating neutrophils in hemorrhage-induced priming for ALI subsequent to septic challenge. Am J Physiol Lung Cell Mol Physiol 290:L51-L58, 2006.
31. Coopersmith CM, Stromberg PE, Dunne WM, Davis CG, Amiot DM 2nd, Buchman TG, Karl IE, Hotchkiss RS: Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis. JAMA 287:1716-1721,2002.
32. Wisnoski N, Chung CS, Chen Y, Huang X, Ayala A: The contribution of cd4+ cd25+ T-regulatory-cells to immune suppression in sepsis. Shock 27:251-257, 2007.
33. Wesche DE, Lomas-Neira JL, Perl M, Chung CS, Ayala A: Leukocyte apoptosis and its significance in sepsis and shock. J Leukoc Biol 78:325-337, 2005.
34. Schneider CP, Nickel EA, Samy TS, Schwacha MG, Cioffi WG, Bland KI, Chaudry IH: The aromatase inhibitor, 4-hydroxyandrostenedione, restores immune responses following trauma-hemorrhage in males and decreases mortality from subsequent sepsis. Shock 14:347-353, 2000.
35. Tsai BM, Wang M, Pitcher JM, Kher A, Brown JW, Meldrum DR: Endothelium-dependent pulmonary artery vasorelaxation is dysfunctional in males but not females after acute lung injury. Surgery 138:78-84, 2005.
36. Thomas P, Dixon MS, Winterton SJ, Sheridan DJ: Acute haemodynamic effects of cromakalim in patients with angina pectoris. Br J Clin Pharmacol 29:325-331, 1990.
37. Bray K, Quast U: Differences in the K(+)-channels opened by cromakalim, acetylcholine and substance P in rat aorta and porcine coronary artery. Br J Pharmacol 102:585-594, 1991.
38. Porto CS, Lazari MF, Abreu LC, Bardin CW, Gunsalus GL: Receptors for androgen-binding proteins: internalization and intracellular signalling. J Steroid Biochem Mol Biol 53:561-565, 1995.
39. Lippert C, Seeger H, Mueck AO, Lippert TH: The effects of A-ring and D-ring metabolites of estradiol on the proliferation of vascular endothelial cells. Life Sci 67:1653-1658, 2000.